[Inhibition of lymphocyte transformation in vitro by protein fractions from the serum of pregnant women and placental extracts].
D000510:Alpha-Globulins / Q000494:pharmacology; D001798:Blood Proteins / Q000494:pharmacology*; D002850:Chromatography, Gel; D005260:Female; D006023:Glycoproteins / Q000494:pharmacology; D006386:Hemagglutination Tests; D006801:Humans; D007122:Immunoelectrophoresis; D007136:Immunoglobulins / Q000494:pharmacology; D007165:Immunosuppression Therapy; D066298:In Vitro Techniques; D037102:Lectins / Q000037:antagonists & inhibitors; D008213:Lymphocyte Activation / Q000187:drug effects*; D008297:Male; D010924:Placental Extracts / Q000494:pharmacology*; D011247:Pregnancy
D000510:Alpha-Globulins; D001798:Blood Proteins; D006023:Glycoproteins; D007136:Immunoglobulins; D037102:Lectins; D010924:Placental Extracts
Zur Hemmung der Lymphozytentransformation in vitro durch Proteinfraktionen aus Schwangerenserum und Plazentaextrakt.